Citation: Md. Segall et al., FIRST PRINCIPLES CALCULATION OF THE ACTIVITY OF CYTOCHROME-P450, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics, 57(4), 1998, pp. 4618-4621
Authors:
ROSTAMIHODJEGAN A
LENNARD MS
WOODS HE
TUCKER GT
Citation: A. Rostamihodjegan et al., METAANALYSIS OF STUDIES OF THE CYP2D6 POLYMORPHISM IN RELATION TO LUNG-CANCER AND PARKINSONS-DISEASE, Pharmacogenetics, 8(3), 1998, pp. 227-238
Authors:
SEGALL MD
PAYNE MC
ELLIS W
TUCKER GT
BOYES N
Citation: Md. Segall et al., EVIDENCE FOR STABILIZATION OF THE LOW-SPIN STATE OF CYTOCHROME-P450 DUE TO SHORTENING OF THE PROXIMAL HEME BOND, Chemical research in toxicology, 11(8), 1998, pp. 962-966
Authors:
SIMOOYA OO
SIJUMBILA G
LENNARD MS
TUCKER GT
Citation: Oo. Simooya et al., HALOFANTRINE AND CHLOROQUINE INHIBIT CYP2D6 ACTIVITY IN HEALTHY ZAMBIANS (VOL 45, PG 315, 1998), British journal of clinical pharmacology, 46(4), 1998, pp. 414-414
Authors:
SIMOOYA OO
SIJUMBIL G
LENNARD MS
TUCKER GT
Citation: Oo. Simooya et al., HALOFANTRINE AND CHLOROQUINE INHIBIT CYP2D6 ACTIVITY IN HEALTHY ZAMBIANS, British journal of clinical pharmacology, 45(3), 1998, pp. 315-317
Authors:
ROSTAMIHODJEGAN A
PEACEY SR
GEORGE E
HELLER SR
TUCKER GT
Citation: A. Rostamihodjegan et al., POPULATION-BASED MODELING TO DEMONSTRATE EXTRAPANCREATIC EFFECTS OF TOLBUTAMIDE, American journal of physiology: endocrinology and metabolism, 37(4), 1998, pp. 758-771
Authors:
ROSTAMIHODJEGAN A
WOLFF K
HAY AWM
CALVERT R
TUCKER GT
Citation: A. Rostamihodjegan et al., POPULATION-KINETICS OF METHADONE IN OPIATE-USERS - CHARACTERIZATION OF TIME-DEPENDENT CHANGES, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4726-4726
Authors:
GHAHRAMANI P
DAVIES SJC
YEO WW
JACKSON PR
TUCKER GT
RAMSAY LE
Citation: P. Ghahramani et al., EFFECT OF CYP2D6 GENETIC-POLYMORPHISM ON SIDE-EFFECTS OF AMITRIPTYLINE AND NORTRIPTYLINE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 51-51
Citation: Md. Segall et al., AB-INITIO MOLECULAR MODELING IN THE STUDY OF DRUG-METABOLISM, European journal of drug metabolism and pharmacokinetics, 22(4), 1997, pp. 283-289
Authors:
WOLFF K
ROSTAMIHODJEGAN A
SHIRES S
HAY AWM
FEELY M
CALVERT R
RAISTRICK D
TUCKER GT
Citation: K. Wolff et al., THE PHARMACOKINETICS OF METHADONE IN HEALTHY-SUBJECTS AND OPIATE USERS, British journal of clinical pharmacology, 44(4), 1997, pp. 325-334
Citation: Ns. Baber et al., THE CLINICAL-SECTION OF THE BRITISH-PHARMACOLOGICAL-SOCIETY - PROSPECTS FOR THE FUTURE, British journal of clinical pharmacology, 44(3), 1997, pp. 215-218
Authors:
GHAHRAMANI P
ELLIS SW
LENNARD MS
RAMSAY LE
TUCKER GT
Citation: P. Ghahramani et al., CYTOCHROMES P450 MEDIATING THE N-DEMETHYLATION OF AMITRIPTYLINE, British journal of clinical pharmacology, 43(2), 1997, pp. 137-144
Citation: Jcw. Marsh et al., CYTOCHROMES P45-2D6 AND 2E1 MUTATIONS ARE NOT ASSOCIATED WITH AN INCREASED RISK OF IDIOSYNCRATIC APLASTIC-ANEMIA, Experimental hematology, 25(8), 1997, pp. 608-608
Authors:
LIN LY
DISTEFANO EW
SCHMITZ DA
HSU L
ELLIS SW
LENNARD MS
TUCKER GT
CHO AK
Citation: Ly. Lin et al., OXIDATION OF METHAMPHETAMINE AND METHYLENEDIOXYMETHAMPHETAMINE BY CYP2D6, Drug metabolism and disposition, 25(9), 1997, pp. 1059-1064
Citation: A. Rostamihodjegan et Gt. Tucker, IS C-MAX AUC USEFUL FOR BIOEQUIVALENCE TESTING/, Journal of pharmaceutical sciences, 86(12), 1997, pp. 1504-1505
Authors:
PEACEY SR
ROSTAMIHODJEGAN A
GEORGE E
TUCKER GT
HELLER SR
Citation: Sr. Peacey et al., THE USE OF TOLBUTAMIDE-INDUCED HYPOGLYCEMIA TO EXAMINE THE INTRAISLETROLE OF INSULIN IN MEDIATING GLUCAGON-RELEASE IN NORMAL HUMANS, The Journal of clinical endocrinology and metabolism, 82(5), 1997, pp. 1458-1461
Citation: Ms. Lennard et al., THE 4-HYDROXYLATION OF TAMOXIFEN BY HUMAN LIVER CYTOCHROMES P450 2D6,2C9 AND 3A4, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 37-37
Citation: Hk. Crewe et al., VARIABLE CONTRIBUTION OF CYTOCHROMES P450 2D6, 2C9 AND 3A4 TO THE 4-HYDROXYLATION OF TAMOXIFEN BY HUMAN LIVER-MICROSOMES, Biochemical pharmacology, 53(2), 1997, pp. 171-178
Authors:
JENNINGS M
SWEETLAND H
SMITH CAD
WOLF CR
LENNARD MS
TUCKER GT
WOODS HF
ROGERS K
Citation: M. Jennings et al., LACK OF RELATIONSHIPS BETWEEN THE DEBRISOQUINE (CYP2D6) AND MEPHENYTION (CYP2C19) OXIDATION POLYMORPHISMS AND SUSCEPTIBILITY TO BREAST-CANCER, Breast, 5(4), 1996, pp. 254-258
Authors:
ROSTAMIHODJEGAN A
NURMINEN S
JACKSON PR
TUCKER GT
Citation: A. Rostamihodjegan et al., CAFFEINE URINARY METABOLITE RATIOS AS MARKERS OF ENZYME-ACTIVITY - A THEORETICAL ASSESSMENT, Pharmacogenetics, 6(2), 1996, pp. 121-149
Authors:
PEACEY SR
GEORGE E
ROSTAMIHODJEGAN A
BEDFORD C
HARRIS N
HARDISTY CA
TUCKER GT
MACDONALD IA
HELLER SR
Citation: Sr. Peacey et al., SIMILAR PHYSIOLOGICAL AND SYMPTOMATIC RESPONSES TO SULFONYLUREA AND INSULIN-INDUCED HYPOGLYCEMIA IN NORMAL SUBJECTS, Diabetic medicine, 13(7), 1996, pp. 634-641
Authors:
WOLFF K
HAY AWM
SHIRES S
FEELY M
CALVERT R
ROSTAMIHODJEGAN A
TUCKER GT
Citation: K. Wolff et al., SINGLE-DOSE PHARMACOKINETICS OF METHADONE IN HEALTHY-SUBJECTS, British journal of clinical pharmacology, 42(5), 1996, pp. 670-670